High OCT4 Expression Might Be Associated with an Aggressive Phenotype in Rectal Cancer
Author:
Lambis-Anaya Lina1, Fernández-Ruiz Mashiel1ORCID, Liscano Yamil2ORCID, Suarez-Causado Amileth1
Affiliation:
1. Grupo Prometeus & Biomedicina Aplicada a las Ciencias Clínicas, Facultad de Medicina, Universidad de Cartagena, Cartagena 130014, Colombia 2. Grupo de Investigación en Salud Integral (GISI), Departamento Facultad de Salud, Universidad Santiago de Cali, Cali 760035, Colombia
Abstract
Rectal cancer (RC) is one of the most common malignant neoplasms, and cancer stem cells (CSCs) of the intestinal tract have been implicated in its origin. The oncofetal protein OCT4 has been linked to neoplastic processes, but its role and clinical significance in RC are unknown. This study investigates the expression of the stem cell marker OCT4 related to clinical-pathological characteristics and its clinical significance in RC patients. The expression level of stem cell marker OCT4 was analyzed in 22 primary rectal tumors by western blot. The association between OCT4 protein expression and the clinical-pathological features of tumors was evaluated by χ2 test and Fisher’s exact test. We demonstrated that the expression of the stem cell marker OCT4 was observed in tumor tissue but not adjacent non-tumor tissue. High expression of the stem cell marker OCT4 was significantly associated with histological differentiation grade (p = 0.039), tumor invasion level (p = 0.004), lymph node involvement (p = 0.044), tumor-node-metastasis (TNM) stage (p = 0.002), and clinical stage (p = 0.021). These findings suggest that high OCT4 expression is associated with a more aggressive RC phenotype, with a greater likelihood of progression and metastasis. These results shed light on the importance of targeting this CSC marker to attenuate RC progression.
Funder
COLCIENCIAS MINCIENCIAS
Subject
Cancer Research,Oncology
Reference48 articles.
1. Ferlay, J., Ervik, M., Lam, F., Colombet, M., Mery, L., Piñeros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2022, April 19). Global Cancer Observatory (GLOBOCAN): Cancer Today. Available online: https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf. 2. Management of Rectal Cancer;Schlechter;Hematol Oncol. Clin. N. Am.,2022 3. Paschke, S., Jafarov, S., Staib, L., Kreuser, E.D., Maulbecker-Armstrong, C., Roitman, M., Holm, T., Harris, C.C., Link, K.H., and Kornmann, M. (2018). Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer. Int. J. Mol. Sci., 19. 4. Prolonged neoadjuvant chemotherapy without radiation versus total neoadjuvant therapy for locally advanced rectal cancer: A propensity score matched study;Zhao;Front. Oncol.,2022 5. Long Non-coding RNA TPT1-AS1 Suppresses APC Transcription in a STAT1-Dependent Manner to Increase the Stemness of Colorectal Cancer Stem Cells;Chen;Mol. Biotechnol.,2022
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|